Abano Healthcare Group Limited Declares Final Fiscal Year 2018 Partially Imputed Dividend, with Payment Date on 20 August 2018

Abano Healthcare Group Limited is a healthcare and medical services provider. The Company's segments include Dental, Audiology, Diagnostics, Rehabilitation and Corporate. The Dental segment is engaged in providing a range of general and specialist dental work, including restorative and cosmetic dental services. The Company operates dental businesses in New Zealand and Australia. Its Diagnostics segment comprises radiology businesses operating in New Zealand. It provides total imaging services, including Ultrasound Scanning, Mammography, Interventional Radiology, Angiography, Magnetic resonance imaging (MRI) Scanning and others. The audiology segment is engaged in providing professional clinical audiology services, particularly hearing tests, the supply and fitting of hearing aid devices, and follow up consultations, all of which are provided to both private patients, as well as publicly funded patients. It operates audiology businesses in Australia, Malaysia, Singapore and Taiwan.